| 저자(한글) |
Tharavichtikul, Ekkasit,Meungwong, Pooriwat,Chitapanarux, Taned,Chakrabandhu, Somvilai,Klunklin, Pitchayaponne,Onchan, Wimrak,Wanwilairat, Somsak,Traisathit, Patrinee,Galalae, Razvan,Chitapanarux, Imj |
| 초록 |
Purpose: To evaluate association between equivalent dose in 2 Gy (EQD2) to rectal point dose and gastrointestinal toxicity from whole pelvic radiotherapy (WPRT) and intracavitary brachytherapy (ICBT) in cervical cancer patients who were evaluated by rectosigmoidoscopy in Faculty of Medicine, Chiang Mai University. Materials and Methods: Retrospective study was designed for the patients with locally advanced cervical cancer, treated by radical radiotherapy from 2004 to 2009 and were evaluated by rectosigmoidoscopy. The cumulative doses of WPRT and ICBT to the maximally rectal point were calculated to the EQD2 and evaluated the association of toxicities. Results: Thirty-nine patients were evaluated for late rectal toxicity. The mean cumulative dose in term of EQD2 to rectum was 64.2 Gy. Grade 1 toxicities were the most common findings. According to endoscopic exam, the most common toxicities were congested mucosa (36 patients) and telangiectasia (32 patients). In evaluation between rectal dose in EQD2 and toxicities, no association of cumulative rectal dose to rectal toxicity, except the association of cumulative rectal dose in EQD2 gt;65 Gy to late effects of normal tissue (LENT-SOMA) scale ${ geq}$ grade 2 (p = 0.022; odds ratio, 5.312; 95% confidence interval, 1.269-22.244). Conclusion: The cumulative rectal dose in EQD2 gt;65 Gy have association with ${ geq}$ grade 2 LENT-SOMA scale. |
